It's How Medicine Should Be®
<< Previous | New Search | Return to Search Results | Next >>

Physician Profile


call (888) 352-RUSH for help arranging an appointment

Bryan A. Bernard, PhD

  • Neuropsychology, Clinical
  • Psychology, Clinical
Board Certification:
  • Clinical Neuropsychology
Faculty Rank: Assistant Professor
Medical or Graduate Education: Louisiana State University
Residency: Rush University Medical Center - Clinical Neuropsychology
Clinical Expertise:
  • Attention deficit hyperactivity disorder (ADHD)
  • Dementia
  • Learning disabilities
  • Movement disorders, psychological symptoms
  • Neuropsychological assessment
  • Stroke, cognitive effects
Research Interests:
  • Cognition in movement disorders
  • Tourette's syndrome outcomes
Google Map

Below is a list of scientific publications for which this practitioner was either the primary author or a contributor. Citations come from PubMed, a database of biomedical literature, life science journals and online books. PubMed is a service of the US Library of Medicine at the National Institutes of Health. Click on the title of the cited work for more information (this will take you directly to Listings go back five years.

  1. Cognitive profile of LRRK2-related Parkinson's disease.
    Srivatsal S, Cholerton B, Leverenz JB, Wszolek ZK, Uitti RJ, Dickson DW, Weintraub D, Trojanowski JQ, Van Deerlin VM, Quinn JF, Chung KA, Peterson AL, Factor SA, Wood-Siverio C, Goldman JG, Stebbins GT, Bernard B, Ritz B, Rausch R, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Mata IF, Hu SC, Montine KS, Johnson C, Montine TJ, Edwards KL, Zhang J, Zabetian CP
    Mov. Disord.
    2015 Feb 4
  2. GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.
    Mata IF, Leverenz JB, Weintraub D, Trojanowski JQ, Chen-Plotkin A, Van Deerlin VM, Ritz B, Rausch R, Factor SA, Wood-Siverio C, Quinn JF, Chung KA, Peterson-Hiller AL, Goldman JG, Stebbins GT, Bernard B, Espay AJ, Revilla FJ, Devoto J, Rosenthal LS, Dawson TM, Albert MS, Tsuang D, Huston H, Yearout D, Hu SC, Cholerton BA, Montine TJ, Edwards KL, Zabetian CP
    Mov. Disord.
    2015 Aug 21
  3. Comparison of the Movement Disorder Society Parkinson's disease dementia criteria with neuropsychological testing.
    Barton BR, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG
    Mov. Disord.
    2014 May 13
  4. Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations.
    Goldman JG, Stebbins GT, Dinh V, Bernard B, Merkitch D, deToledo-Morrell L, Goetz CG
    2014 Mar
    137(Pt 3):849-59.
  5. Diagnosing PD-MCI by MDS task force criteria: How many and which neuropsychological tests?
    Goldman JG, Holden S, Ouyang B, Bernard B, Goetz CG, Stebbins GT
    Mov. Disord.
    2014 Dec 1
  6. New observations in the fragile X-associated tremor/ataxia syndrome (FXTAS) phenotype.
    Fraint A, Vittal P, Szewka A, Bernard B, Berry-Kravis E, Hall DA
    Front Genet
  7. Immediate vs. delayed treatment of psychogenic movement disorders with short term psychodynamic psychotherapy: Randomized clinical trial.
    Kompoliti K, Wilson B, Stebbins G, Bernard B, Hinson V
    Parkinsonism Relat. Disord.
    2013 Sep 22
  8. Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.
    Goldman JG, Holden S, Bernard B, Ouyang B, Goetz CG, Stebbins GT
    Mov. Disord.
    2013 Oct 9
  9. Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease.
    Goldman JG, Ghode RA, Ouyang B, Bernard B, Goetz CG, Stebbins GT.
    Parkinsonism Relat Disord. 2013
    2013 Jun 2. doi:pii: S1353-8020(13)00193-4. 10.1016/j.parkreldis.2013.05.006. [Epub ahead of print]
  10. Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia.
    Goldman JG, Stebbins GT, Bernard B, Stoub TR, Goetz CG, deToledo-Morrell L.
    Mov Disord. 2012
    2012 May
    27(6):727-34. doi: 10.1002/mds.24938. Epub 2012 Mar 12.
  11. Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia.
    Barton B, Grabli D, Bernard B, Czernecki V, Goldman JG, Stebbins G, Dubois B, Goetz CG.
    Mov Disord. 2012
    2012 Feb
    27(2):248-53. doi: 10.1002/mds.24059. Epub 2011 Dec 9.
  12. Clinical differences among mild cognitive impairment subtypes in Parkinson's disease.
    Goldman JG, Weis H, Stebbins G, Bernard B, Goetz CG.
    Mov Disord. 2012
    2012 Aug
    27(9):1129-36. doi: 10.1002/mds.25062. Epub 2012 Jul 6.
  13. The Montreal Cognitive Assessment as a screening tool for cognitive dysfunction in Huntington's disease.
    Videnovic A, Bernard B, Fan W, Jaglin J, Leurgans S, Shannon KM.
    Mov Disord. 2010
    2010 Feb 15
    25(3):401-4. doi: 10.1002/mds.22748.
  14. Determinants of quality of life in children with Gilles de la Tourette syndrome.
    Bernard BA, Stebbins GT, Siegel S, Schultz TM, Hays C, Morrissey MJ, Leurgans S, Goetz CG.
    Mov Disord. 2009
    2009 May 15
    24(7):1070-3. doi: 10.1002/mds.22487.
  • (If you cannot play the video, you may need to update to the latest version of Adobe Flash Player.)
  • View Transcript